↓ Skip to main content

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

Overview of attention for article published in Molecular Cancer, October 2007
Altmetric Badge

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Published in
Molecular Cancer, October 2007
DOI 10.1186/1476-4598-6-66
Pubmed ID
Authors

Larisa L Belyanskaya, Thomas M Marti, Sally Hopkins-Donaldson, Stefanie Kurtz, Emanuela Felley-Bosco, Rolf A Stahel

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Poland 1 3%
Unknown 37 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 28%
Student > Master 7 18%
Student > Bachelor 5 13%
Student > Ph. D. Student 5 13%
Other 3 8%
Other 3 8%
Unknown 6 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 35%
Biochemistry, Genetics and Molecular Biology 10 25%
Pharmacology, Toxicology and Pharmaceutical Science 4 10%
Medicine and Dentistry 4 10%
Immunology and Microbiology 1 3%
Other 0 0%
Unknown 7 18%